Cargando…
Multiple mechanisms underlying acquired resistance to taxanes in selected docetaxel-resistant MCF-7 breast cancer cells
BACKGROUND: Chemoresistance is a major factor involved in a poor response and reduced overall survival in patients with advanced breast cancer. Although extensive studies have been carried out to understand the mechanisms of chemoresistance, many questions remain unanswered. METHODS: In this researc...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3900991/ https://www.ncbi.nlm.nih.gov/pubmed/24447372 http://dx.doi.org/10.1186/1471-2407-14-37 |
_version_ | 1782300785581752320 |
---|---|
author | Wang, Harris Vo, The Hajar, Ali Li, Sarah Chen, Xinmei Parissenti, Amadeo M Brindley, David N Wang, Zhixiang |
author_facet | Wang, Harris Vo, The Hajar, Ali Li, Sarah Chen, Xinmei Parissenti, Amadeo M Brindley, David N Wang, Zhixiang |
author_sort | Wang, Harris |
collection | PubMed |
description | BACKGROUND: Chemoresistance is a major factor involved in a poor response and reduced overall survival in patients with advanced breast cancer. Although extensive studies have been carried out to understand the mechanisms of chemoresistance, many questions remain unanswered. METHODS: In this research, we used two isogenic MCF-7 breast cancer cell lines selected for resistance to doxorubicin (MCF-7(DOX)) or docetaxel (MCF-7(TXT)) and the wild type parental cell line (MCF-7(CC)) to study mechanisms underlying acquired resistance to taxanes in MCF-7(TXT) cells. Cytotoxicity assay, immunoblotting, indirect immunofluorescence and live imaging were used to study the drug resistance, the expression levels of drug transporters and various tubulin isoforms, apoptosis, microtubule formation, and microtubule dynamics. RESULTS: MCF-7(TXT) cells were cross resistant to paclitaxel, but not to doxorubicin. MCF-7(DOX) cells were not cross-resistant to taxanes. We also showed that multiple mechanisms are involved in the resistance to taxanes in MCF-7(TXT) cells. Firstly, MCF-7(TXT) cells express higher level of ABCB1. Secondly, the microtubule dynamics of MCF-7(TXT) cells are weak and insensitive to the docetaxel treatment, which may partially explain why docetaxel is less effective in inducing M-phase arrest and apoptosis in MCF-7(TXT) cells in comparison with MCF-7(CC) cells. Moreover, MCF-7(TXT) cells express relatively higher levels of β2- and β4-tubulin and relatively lower levels of β3-tubulin than both MCF-7(CC) and MCF-7(DOX) cells. The subcellular localization of various β-tubulin isoforms in MCF-7(TXT) cells is also different from that in MCF-7(CC) and MCF-7(DOX) cells. CONCLUSION: Multiple mechanisms are involved in the resistance to taxanes in MCF-7(TXT) cells. The high expression level of ABCB1, the specific composition and localization of β-tubulin isoforms, the weak microtubule dynamics and its insensitivity to docetaxel may all contribute to the acquired resistance of MCF-7(TXT) cells to taxanes. |
format | Online Article Text |
id | pubmed-3900991 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-39009912014-01-25 Multiple mechanisms underlying acquired resistance to taxanes in selected docetaxel-resistant MCF-7 breast cancer cells Wang, Harris Vo, The Hajar, Ali Li, Sarah Chen, Xinmei Parissenti, Amadeo M Brindley, David N Wang, Zhixiang BMC Cancer Research Article BACKGROUND: Chemoresistance is a major factor involved in a poor response and reduced overall survival in patients with advanced breast cancer. Although extensive studies have been carried out to understand the mechanisms of chemoresistance, many questions remain unanswered. METHODS: In this research, we used two isogenic MCF-7 breast cancer cell lines selected for resistance to doxorubicin (MCF-7(DOX)) or docetaxel (MCF-7(TXT)) and the wild type parental cell line (MCF-7(CC)) to study mechanisms underlying acquired resistance to taxanes in MCF-7(TXT) cells. Cytotoxicity assay, immunoblotting, indirect immunofluorescence and live imaging were used to study the drug resistance, the expression levels of drug transporters and various tubulin isoforms, apoptosis, microtubule formation, and microtubule dynamics. RESULTS: MCF-7(TXT) cells were cross resistant to paclitaxel, but not to doxorubicin. MCF-7(DOX) cells were not cross-resistant to taxanes. We also showed that multiple mechanisms are involved in the resistance to taxanes in MCF-7(TXT) cells. Firstly, MCF-7(TXT) cells express higher level of ABCB1. Secondly, the microtubule dynamics of MCF-7(TXT) cells are weak and insensitive to the docetaxel treatment, which may partially explain why docetaxel is less effective in inducing M-phase arrest and apoptosis in MCF-7(TXT) cells in comparison with MCF-7(CC) cells. Moreover, MCF-7(TXT) cells express relatively higher levels of β2- and β4-tubulin and relatively lower levels of β3-tubulin than both MCF-7(CC) and MCF-7(DOX) cells. The subcellular localization of various β-tubulin isoforms in MCF-7(TXT) cells is also different from that in MCF-7(CC) and MCF-7(DOX) cells. CONCLUSION: Multiple mechanisms are involved in the resistance to taxanes in MCF-7(TXT) cells. The high expression level of ABCB1, the specific composition and localization of β-tubulin isoforms, the weak microtubule dynamics and its insensitivity to docetaxel may all contribute to the acquired resistance of MCF-7(TXT) cells to taxanes. BioMed Central 2014-01-22 /pmc/articles/PMC3900991/ /pubmed/24447372 http://dx.doi.org/10.1186/1471-2407-14-37 Text en Copyright © 2014 Wang et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Wang, Harris Vo, The Hajar, Ali Li, Sarah Chen, Xinmei Parissenti, Amadeo M Brindley, David N Wang, Zhixiang Multiple mechanisms underlying acquired resistance to taxanes in selected docetaxel-resistant MCF-7 breast cancer cells |
title | Multiple mechanisms underlying acquired resistance to taxanes in selected docetaxel-resistant MCF-7 breast cancer cells |
title_full | Multiple mechanisms underlying acquired resistance to taxanes in selected docetaxel-resistant MCF-7 breast cancer cells |
title_fullStr | Multiple mechanisms underlying acquired resistance to taxanes in selected docetaxel-resistant MCF-7 breast cancer cells |
title_full_unstemmed | Multiple mechanisms underlying acquired resistance to taxanes in selected docetaxel-resistant MCF-7 breast cancer cells |
title_short | Multiple mechanisms underlying acquired resistance to taxanes in selected docetaxel-resistant MCF-7 breast cancer cells |
title_sort | multiple mechanisms underlying acquired resistance to taxanes in selected docetaxel-resistant mcf-7 breast cancer cells |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3900991/ https://www.ncbi.nlm.nih.gov/pubmed/24447372 http://dx.doi.org/10.1186/1471-2407-14-37 |
work_keys_str_mv | AT wangharris multiplemechanismsunderlyingacquiredresistancetotaxanesinselecteddocetaxelresistantmcf7breastcancercells AT vothe multiplemechanismsunderlyingacquiredresistancetotaxanesinselecteddocetaxelresistantmcf7breastcancercells AT hajarali multiplemechanismsunderlyingacquiredresistancetotaxanesinselecteddocetaxelresistantmcf7breastcancercells AT lisarah multiplemechanismsunderlyingacquiredresistancetotaxanesinselecteddocetaxelresistantmcf7breastcancercells AT chenxinmei multiplemechanismsunderlyingacquiredresistancetotaxanesinselecteddocetaxelresistantmcf7breastcancercells AT parissentiamadeom multiplemechanismsunderlyingacquiredresistancetotaxanesinselecteddocetaxelresistantmcf7breastcancercells AT brindleydavidn multiplemechanismsunderlyingacquiredresistancetotaxanesinselecteddocetaxelresistantmcf7breastcancercells AT wangzhixiang multiplemechanismsunderlyingacquiredresistancetotaxanesinselecteddocetaxelresistantmcf7breastcancercells |